499 related articles for article (PubMed ID: 33271119)
21. Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.
Chang CC; Pirozzi G; Wen SH; Chung IH; Chiu BL; Errico S; Luongo M; Lombardi ML; Ferrone S
J Biol Chem; 2015 Oct; 290(44):26562-75. PubMed ID: 26381407
[TBL] [Abstract][Full Text] [Related]
22. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.
Ameres S; Mautner J; Schlott F; Neuenhahn M; Busch DH; Plachter B; Moosmann A
PLoS Pathog; 2013; 9(5):e1003383. PubMed ID: 23717207
[TBL] [Abstract][Full Text] [Related]
23. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
24. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
25. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
26. SPPL3-dependent downregulation of the synthesis of (neo)lacto-series glycosphingolipid is required for the staining of cell surface CD59.
Kawaguchi K; Yamamoto-Hino M; Goto S
Biochem Biophys Res Commun; 2021 Sep; 571():81-87. PubMed ID: 34303967
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma.
Sabbatino F; Villani V; Yearley JH; Deshpande V; Cai L; Konstantinidis IT; Moon C; Nota S; Wang Y; Al-Sukaini A; Zhu AX; Goyal L; Ting DT; Bardeesy N; Hong TS; Fernandez-del Castillo C; Tanabe KK; Lillemoe KD; Ferrone S; Ferrone CR
Clin Cancer Res; 2016 Jan; 22(2):470-8. PubMed ID: 26373575
[TBL] [Abstract][Full Text] [Related]
28. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
[TBL] [Abstract][Full Text] [Related]
29. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
Sullivan LC; Clements CS; Rossjohn J; Brooks AG
Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
[TBL] [Abstract][Full Text] [Related]
30. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
Montealegre S; van Endert PM
Front Immunol; 2018; 9():3098. PubMed ID: 30666258
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.
Kang W; Sung PS; Park SH; Yoon S; Chang DY; Kim S; Han KH; Kim JK; Rehermann B; Chwae YJ; Shin EC
Gastroenterology; 2014 May; 146(5):1351-60.e1-4. PubMed ID: 24486950
[TBL] [Abstract][Full Text] [Related]
32. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Dhatchinamoorthy K; Colbert JD; Rock KL
Front Immunol; 2021; 12():636568. PubMed ID: 33767702
[TBL] [Abstract][Full Text] [Related]
33. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
Rouas-Freiss N; Moreau P; Menier C; LeMaoult J; Carosella ED
Semin Cancer Biol; 2007 Dec; 17(6):413-21. PubMed ID: 17881247
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.
Klar R; Schober S; Rami M; Mall S; Merl J; Hauck SM; Ueffing M; Admon A; Slotta-Huspenina J; Schwaiger M; Stevanović S; Oostendorp RA; Busch DH; Peschel C; Krackhardt AM
Leukemia; 2014 Dec; 28(12):2355-66. PubMed ID: 24736212
[TBL] [Abstract][Full Text] [Related]
35. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
36. Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.
Madsen CB; Petersen C; Lavrsen K; Harndahl M; Buus S; Clausen H; Pedersen AE; Wandall HH
PLoS One; 2012; 7(11):e50139. PubMed ID: 23189185
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humans.
Gervassi AL; Probst P; Stamm WE; Marrazzo J; Grabstein KH; Alderson MR
J Immunol; 2003 Oct; 171(8):4278-86. PubMed ID: 14530352
[TBL] [Abstract][Full Text] [Related]
38. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.
Croft NP; Shannon-Lowe C; Bell AI; Horst D; Kremmer E; Ressing ME; Wiertz EJ; Middeldorp JM; Rowe M; Rickinson AB; Hislop AD
PLoS Pathog; 2009 Jun; 5(6):e1000490. PubMed ID: 19557156
[TBL] [Abstract][Full Text] [Related]
39. T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.
Reuben A; Godin-Ethier J; Santos MM; Lapointe R
Mol Immunol; 2015 Jun; 65(2):259-66. PubMed ID: 25700349
[TBL] [Abstract][Full Text] [Related]
40. Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation.
Togayachi A; Kozono Y; Ikehara Y; Ito H; Suzuki N; Tsunoda Y; Abe S; Sato T; Nakamura K; Suzuki M; Goda HM; Ito M; Kudo T; Takahashi S; Narimatsu H
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11900-5. PubMed ID: 20547865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
